News

Team UNC Oncology among top fundraising teams for Light The Night Walk

Team UNC Oncology among top fundraising teams for Light The Night Walk

The Leukemia & Lymphoma Society (LLS) held their Light The Night Walk at Rock Quarry Park in Durham on Saturday, September 20. The evening fundraising walk celebrated and commemorated lives touched by blood cancer. More than a walk, the evening had a carnival atmosphere and included refreshments, entertainment, music and kids' activities

Team UNC Oncology among top fundraising teams for Light The Night Walk - Read More…

Genomic profiling of Kaposi Sarcoma in Malawi

Genomic profiling of Kaposi Sarcoma in Malawi

Mina Hosseinipour, MD of UNC Project Malawi, Kristen Sweet, PhD student in Dirk Dittmer's group, and co-authors have published the results of transcriptional profiling of Kaposi Sarcomas seen in Malawi in the September 2014 issue of MBio. This report identified two molecular subtypes of Kaposi Sarcoma, which is the most common cancer in men in Malawi.

Genomic profiling of Kaposi Sarcoma in Malawi - Read More…

UNC Lineberger hosts Metastatic Breast Cancer Network Conference

UNC Lineberger hosts Metastatic Breast Cancer Network Conference

The Metastatic Breast Cancer Network (MBCN) held its 8th Annual National Conference in Chapel Hill September 19-21, 2014 in conjunction with the UNC Lineberger Comprehensive Cancer Center.

UNC Lineberger hosts Metastatic Breast Cancer Network Conference - Read More…

Nielsen named Director of UNC Urologic Oncology

Nielsen named Director of UNC Urologic Oncology

Matthew Nielsen, MD, MS, assistant professor of urology and adjunct assistant professor of epidemiology and health policy & management, has been named director of urologic oncology in the UNC Department of Urology. In his new role, he joins Matthew Milowsky, MD, associate professor of medicine, as co-director of the Multidisciplinary Genitourinary Oncology Service at the N.C. Cancer Hospital.

Nielsen named Director of UNC Urologic Oncology - Read More…

Sharon Campbell honored at the 2014 Hyman L. Battle Distinguished Cancer Research Award reception

Sharon Campbell honored at the 2014 Hyman L. Battle Distinguished Cancer Research Award reception

On September 24, 2014, UNC Lineberger held a reception to honor Dr. Sharon Campbell, recipient of the 2014 Hyman L. Battle Distinguished Cancer Research Award.

Sharon Campbell honored at the 2014 Hyman L. Battle Distinguished Cancer Research Award reception - Read More…

The Geneticist

The Geneticist

With his selection to the NIH Council of Councils, Terry Magnuson, PhD, becomes the first UNC scientist appointed to the board dedicated to funding the biggest ideas in medical research.

The Geneticist - Read More…

UNC researchers find final pieces to the circadian clock puzzle

UNC researchers find final pieces to the circadian clock puzzle

Sixteen years after scientists found the genes that control the circadian clock in all cells, the lab of UNC’s Aziz Sancar, MD, PhD, discovered the mechanisms responsible for keeping the clock in sync.

UNC researchers find final pieces to the circadian clock puzzle - Read More…

Damania appointed Assistant Dean for Research

Damania appointed Assistant Dean for Research

Blossom Damania, PhD, professor of microbiology and immunology, has been named Assistant Dean for Research at the UNC School of Medicine, effective immediately.

Damania appointed Assistant Dean for Research - Read More…

Basch contributes to new ASCO guidelines for prostate cancer treatment

Basch contributes to new ASCO guidelines for prostate cancer treatment

New clinical guidelines have been announced for the treatment of men with metastatic castration-resistant prostate cancer (CRPC) by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO). Ethan Basch, MD, director of the Cancer Outcomes Research Program at UNC Lineberger Comprehensive Cancer Center, served as the co-chair of the ASCO/CCO expert panel that developed the guideline.

Basch contributes to new ASCO guidelines for prostate cancer treatment - Read More…

UNC researchers find new genetic target for a different kind of cancer drug

UNC researchers find new genetic target for a different kind of cancer drug

Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that UNC researcher Zefeng Wang, PhD, discovered is drastically reduced in human lung and breast cancer cells.

UNC researchers find new genetic target for a different kind of cancer drug - Read More…

Popular cancer drug target implicated in cardiovascular defects

Popular cancer drug target implicated in cardiovascular defects

Research led by UNC’s Kathleen Caron, PhD, shows that halting the protein CXCR7 leads to over activation of adrenomedullin, a hormone needed at proper levels for normal cardiovascular development

Popular cancer drug target implicated in cardiovascular defects - Read More…

Changing the face of clinical trials

Changing the face of clinical trials

UNC Lineberger secures three major NCI grants to advance the nation’s clinical trials program.

Changing the face of clinical trials - Read More…

Anders presents at 13th Annual Round Asia Oncology Forum

Anders presents at 13th Annual Round Asia Oncology Forum

Carey Anders, MD, UNC Lineberger member and associate professor, was a presenter and moderator at The 13th Annual Round Asia Oncology Forum (RAOF) in Hong Kong on August 29 - 30, 2014. The theme of this year’s forum was “Expanding our armory in personalized cancer treatment.”

Anders presents at 13th Annual Round Asia Oncology Forum - Read More…

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery

The UNC Eshelman School of Pharmacy has received a $3 million gift from philanthropist and pharmaceutical-industry executive Fred Eshelman. Eshelman’s gift will support the work of the School’s Center for Integrative Chemical Biology and Drug Discovery, led by UNC Lineberger member Stephen Frye, PhD. The center is dedicated to evaluating and developing potential drug targets discovered by UNC faculty.

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery - Read More…

Swenberg and colleagues publish in DNA Repair

James Swenberg, PhD, DVM, DACVP, Environmental Science & Engineering, Cancer Genetics, and additional co-authors have published "The endogenous exposome" in the July 2014 issue of DNA Repair. In the review, authors focused on the endogenous exposome, the DNA damage that arises from the production of endogenous electrophilic molecules in cells.

Swenberg and colleagues publish in DNA Repair - Read More…

Major receives National Cancer Institute Grant

Major receives National Cancer Institute Grant

The National Cancer Institute has awarded Ben Major, PhD, assistant professor of Cell Biology and Physiology, University of North Carolina at Chapel Hill and UNC Lineberger Comprehensive Cancer Center, with an R21 award of $275,000 to support his project “Mass spectrometry-coupled hypermorphic functional genomics”. The goal of the research is to develop gain-of-function screening technology to connect gene overexpression with signal transduction in cancer.

Major receives National Cancer Institute Grant - Read More…

2014 University Cancer Research Fund Innovation Awards announced

Six researchers have been awarded 2014 University Cancer Research Fund (UCRF) Innovation Awards for promoting innovative and new ideas in cancer research at the University of North Carolina at Chapel Hill.

2014 University Cancer Research Fund Innovation Awards announced - Read More…

Field of Hope honors cancer survivors and raises money for Kay Yow Cancer Fund

Field of Hope honors cancer survivors and raises money for Kay Yow Cancer Fund

UNC Health Care and Rex Healthcare co-sponsored “Field of Hope” at the Durham Bulls game on Saturday, August 23 with a portion of special ticket sales going to the Kay Yow Cancer Fund.

Field of Hope honors cancer survivors and raises money for Kay Yow Cancer Fund - Read More…